Composition, form of production and packaging
? Capsules hard gelatinous, with a white body with a creamy shade of color and a lid of a dark green color; diameter of capsules 6.7-6.9 mm, length 19.1-19.7 mm; the contents of the capsules are a light brown powder with a characteristic odor.
1 caps.
thiamine mononitrate (Vit B 1 ) 60 mg
calcium pantothenate (Vit B 5 ) 60 mg
cystine 20 mg
para-aminobenzoic acid 20 mg
keratin 20 mg
medical yeast 100 mg
Excipients: microcrystalline cellulose, talc, magnesium stearate, povidone, silicon dioxide colloid.
The composition of the capsule shell: gelatin, purified water, titanium dioxide, iron oxide, yellow oxide, indigo carmine.
15 pcs. - blisters (2) - cardboard boxes.
15 pcs. - blisters (6) - cardboard boxes.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2010.
PHARMACHOLOGIC EFFECT
A combined preparation containing the components necessary for hair and nail growth - calcium pantothenate, cystine, amino acids, keratin. The effect of the drug is due to the properties of its constituent components.
PHARMACOKINETICS
The action of the drug Panto-vigir is the cumulative effect of its components, therefore it is not possible to carry out kinetic observations.
INDICATIONS
- diffuse hair loss non-hormonal etiology;
- degenerative changes in the structure of the hair (due to chemical effects, hair damage by solar and ultraviolet radiation);
- violation of the structure of the nails.
DOSING MODE
For adults, the drug is prescribed 1 capsule 3 times / day. The drug is recommended to be taken simultaneously with food intake, the capsule should be swallowed whole, without chewing, squeezed with a small amount of liquid.
The duration of treatment is 3-6 months. If necessary, it is possible to increase the duration of the course of treatment or its recurrence.
SIDE EFFECT
Allergic reactions: itching, hives.
From the cardiovascular system: increased heart rate.
From the digestive system: nausea, vomiting, flatulence, abdominal pain.
Other: increased sweating.
CONTRAINDICATIONS
- I and II trimester of pregnancy;
- the period of lactation (breastfeeding);
- childhood;
- Hypersensitivity to the components of the drug.
PREGNANCY AND LACTATION
The drug is contraindicated for use in the I and II trimesters of pregnancy and lactation (breastfeeding).
In the third trimester of pregnancy, the drug can be administered only as directed by the doctor.
APPLICATION FOR CHILDREN
The drug is contraindicated in children.
SPECIAL INSTRUCTIONS
Infectious diseases of nails and androgenic alopecia are not indications for the use of the drug. At the given pathologies the preparation can be used as a part of the combined therapy.
It should be explained to the patient that hair formation is a long process, and therefore the drug should be taken at the indicated doses regularly for 3-6 months.
The patient should be aware that if diseases of the hair or nails take an unfavorable, highly progressive course, it is necessary to consult a doctor again, since these diseases can be symptoms of systemic diseases.
If the patient is taking sulfonamide drugs, he should consult a doctor before taking Panto-vair.
OVERDOSE
No cases of drug overdose were reported.
DRUG INTERACTION
Drug interaction of the drug is not described.
TERMS OF RELEASE FROM PHARMACY
The drug is approved for use as a means of OTC.
TERMS AND CONDITIONS OF STORAGE
The drug should be stored out of reach of children, dry, protected from light at a temperature of no higher than 25 В° C. Shelf life - 3 years.
